Loading…
| # | Company | Offered Item | Amount | Rank | Status |
|---|---|---|---|---|---|
| 1 | L1₹4.7 LQualified Make: NOVARTIS
Model: ACCENTRIX PFS
Title: Accentrix Solution for Injection PFS (Ranibizumab (10mg/ml) ) 16 VIVEK INDUSTRIAL ESTATE WALBHAT RD GOREGAON EAST MUMBAI MUMBAI MAHARASHTRA 400063 | MUMBAI SUBURBAN | MAHARASHTRA | 400063 | Make: NOVARTIS
Model: ACCENTRIX PFS
Title: Accentrix Solution for Injection PFS (Ranibizumab (10mg/ml) ) | L1 | Qualified |
Tender Value
Refer Docs
EMD Value
Exempted
Closing Date
2 Nov 2023, 5:00 pmClosed
Accentrix Solution for Injection PFS (Ranibizumab (10mg/ml) ) (Q3)
5505158
GEM/2023/B/4125942
Two Packet Bid
Accentrix Solution for Injection PFS (Ranibizumab (10mg/ml) )
GeM Contract
15 days
Gujarat; Vadodara
Total value wise evaluation
PRODUCT_CUSTOM
Awarded to K ENTERPRISES
₹4.7 L
| Product | Brand / Model | HSN | Quantity | Unit Price | Amount |
|---|---|---|---|---|---|
| Accentrix Solution for Injection PFS (Ranibizumab (10mg/ml) ) | NOVARTIS / ACCENTRIX PFS | HSN not specified by seller | 25 pieces | 18,625 | 465,625 |
6 documents required · 6 mandatory
3 yrs
50%
| Item | Delivery Location | Qty | Delivery |
|---|---|---|---|
| Accentrix Solution for Injection PFS (Ranibizumab (10mg/ml) ) (Q3) | Jagrutiben Chaudhari 390001,JAILROAD VADODARA | 25 | 15 days |
Exempted
24 Nov 2023
23 Oct 2023
2 Nov 2023
contract_GEMC-511687783349384.pdf
GEM_CONTRACT • 0.05 MB
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_5505158.pdf
GEM_BID
23-10-23_2023-10-23-16-44-17_cea80a5a89ae5b7ecb08d49c08d86509.pdf
SPECIFICATION
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .